J.P. Morgan adds Givaudan to Positive Catalyst Watch on strong Q3 outlook

Goldman Sachs sees upside for Applied Materials stock ahead of earnings

Investing.com · News 14m ago

Radiopharm completes FDA meeting on brain imaging agent RAD101

Investing.com · News 16m ago

Revolution Medicines begins phase 3 trial for pancreatic cancer

Investing.com · News 16m ago

Curaleaf raises Aurora Cannabis takeover bid to $5 per share

Investing.com · News 16m ago

Benitec receives FDA feedback on BB-301 pivotal trial design

Investing.com · News 16m ago

Mayo Lake Minerals plans private placement to raise up to $700,000

Investing.com · News 16m ago

Xtend receives patent for smart payload navigation system

Investing.com · News 16m ago

Rani Therapeutics’ pill platform accepted into FDA program

Investing.com · News 16m ago

Strategy buys 334 bitcoin and holds 848,000 BTC as of October 4

Investing.com · News 19m ago

What’s the Right “Level of Care” for A.I.?

The New York Times · Business 19m ago